###
中国临床研究:2026,39(8):1238-1242,1256
本文二维码信息
码上扫一扫!
高血压及脉压与非动脉炎性视网膜中央动脉阻塞患者预后的关系
(1. 南通大学医学院, 江苏 南通 226000;2. 南通大学附属医院眼科, 江苏 南通 226001)
Associations of hypertension and pulse pressure with prognosis in patients with nonarteritic central retinal artery occlusion
摘要
本文已被:浏览 230次   下载 193次
投稿时间:2025-12-19   网络发布日期:2026-08-25
中文摘要: 目的 探讨高血压及脉压水平与非动脉炎性视网膜中央动脉阻塞(CRAO)治疗后短期视力结局的关系,为临床识别超选择性眼动脉内溶栓(SIAT)疗效不佳的高危人群及风险管理提供依据。方法 回顾性纳入2021年1 月至2025 年11 月南通大学附属医院眼科收治的非动脉炎性CRAO 患者153 例,按治疗方式分为保守治疗组71 例和SIAT 组82 例。比较不同治疗方式及有无高血压、高脉压患者的视力明显改善率;分别在全队列及SIAT 人群构建多因素logistic 回归模型,评估高血压与视力结局的关系,并分析SIAT 组高脉压与视力结局的关系。结果 153例患者中,51.6%患者视力明显改善。SIAT组视力明显改善率为61.0%,显著高于保守治疗组的40.8%(χ2=6.175,P=0.013)。高血压患者视力明显改善率为43.8%,显著低于无高血压患者的62.5%(χ2=5.202,P=0.023)。全队列多因素logistic 回归分析显示,高血压是视力明显改善的不利因素(OR=0.445,95%CI:0.220~0.902,P=0.025);SIAT 治疗是视力明显改善的有利因素(OR=2.138,95%CI:1.028~4.447,P=0.042)。在SIAT 人群的多因素logistic 回归模型中,高血压仍为视力明显改善的不利因素(OR=0.330,95%CI:0.115~0.947,P=0.039)。按脉压分层分析显示,正常脉压组视力改善率为78.8%,高脉压组为49.0%。进一步在SIAT 亚组多因素模型中发现,高脉压是视力明显改善的独立负性预测因素(OR=0.237,95%CI:0.075~0.745,P=0.014)。结论 在非动脉炎性CRAO患者中,介入溶栓较保守治疗更有利于短期视力改善;高血压影响视力预后。在接受SIAT治疗的患者中,高脉压与溶栓疗效不佳有关,提示高脉压可作为识别溶栓视力获益较差人群的临床指标。
Abstract:Objective To investigate the associations of hypertension and pulse pressure with short-term visual outcomes in patients with nonarteritic central retinal artery occlusion (CRAO)after treatment,and to provide evidence for identifying patients at high risk of poor response to superselective intra-ophthalmic arterial thrombolysis(SIAT)and optimizing risk management. Methods A retrospective study was conducted on 153 patients with nonarteritic CRAO admitted to the Department of Ophthalmology,Affiliated Hospital of Nantong University from January 2021 to November 2025. Patients were divided into a conservative treatment group(n=71)and a SIAT group(n=82)according to the treatment received. The rates of significant visual improvement were compared between treatment groups and between patients with and without hypertension,as well as between patients with normal and elevated pulse pressure.Multivariable logistic regression analyses were performed in the overall cohort and in the SIAT subgroup to evaluate the association between hypertension and visual outcomes. In addition,the relationship between elevated pulse pressure and visual outcomes was analyzed in the SIAT subgroup. Results Among the 153 patients,51.6% achieved significant visual improvement. The rate of significant visual improvement was significantly higher in the SIAT group than in the conservative treatment group(61.0% vs 40.8%,χ2=6.175,P=0.013). Patients with hypertension had a significantly lower rate of visual improvement than those without hypertension(43.8% vs 62.5%,χ2=5.202,P=0.023). Multivariable logistic regression analysis of the overall cohort showed that hypertension was an unfavorable factor for significant visual improvement(OR=0.445,95%CI:0.220-0.902,P=0.025),whereas SIAT was a favorable factor(OR=2.138,95%CI:1.028-4.447,P=0.042). In the multivariable logistic regression model of the SIAT subgroup,hypertension remained an independent unfavorable factor for significant visual improvement(OR=0.330,95%CI:0.115-0.947,P=0.039). Stratified analysis by pulse pressure showed that the rate of significant visual improvement was 78.8% in the normal pulse pressure group and 49.0% in the elevated pulse pressure group. Furthermore,multivariable analysis in the SIAT subgroup demonstrated that elevated pulse pressure was an independent negative predictor of significant visual improvement(OR=0.237,95%CI:0.075-0.745,P=0.014). Conclusions In patients with nonarteritic CRAO,intra-arterial thrombolysis is associated with better short-term visual improvement than conservative treatment,while hypertension adversely affects visual prognosis. Among patients undergoing SIAT,elevated pulse pressure is associated with a poorer therapeutic response,suggesting that elevated pulse pressure may serve as a useful clinical indicator for identifying patients less likely to achieve visual benefit from thrombolytic therapy.
文章编号:     中图分类号:R774.1    文献标志码:A
基金项目:江苏省卫生健康委科研项目(M2024045);南通大学医学院低视力康复新型技术和体系的研发项目(23ZH313)
附件
引用文本:
鱼佳皓,蔡玲,汤澜,等.高血压及脉压与非动脉炎性视网膜中央动脉阻塞患者预后的关系[J].中国临床研究,2026,39(8):1238-1242,1256.

用微信扫一扫

用微信扫一扫